Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis
- Zien Zhou
- , Meg J. Jardine
- , Qiang Li
- , Brendon L. Neuen
- , Christopher P. Cannon
- , Dick De Zeeuw
- , Robert Edwards
- , Adeera Levin
- , Kenneth W. Mahaffey
- , Vlado Perkovic
- , Bruce Neal
- , Richard I. Lindley*
- , CREDENCE Trial Investigators including
- , Srikanth Bellary
*Corresponding author for this work
- University of New South Wales, Australia
- Renji Hospital
- Concord Repatriation General Hospital
- Brigham and Women's Hospital
- University of Groningen, University Medical Center Groningen
- Janssen Research & Development
- University of British Columbia
- Stanford University School of Medicine
- Royal North Shore Hospital
- University of Sydney
- Royal Brompton Hospital
- The George Institute for Global Health
Research output: Contribution to journal › Article › peer-review
100
Link opens in a new tab
Citations
(SciVal)
44
Downloads
(Pure)